HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wim J M Van de Ven Selected Research

Neoplasms (Cancer)

6/2016Synthesis and Characterization of Curcumin-Functionalized HP-β-CD-Modified GoldMag Nanoparticles as Drug Delivery Agents.
2/2016Emerging role of PLAG1 as a regulator of growth and reproduction.
8/2013Curcumin affects proprotein convertase activity: elucidation of the molecular and subcellular mechanism.
1/2012A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy.
10/2008Adenomyoepitheliomatous lesions of the mammary glands in transgenic mice with targeted PLAG1 overexpression.
2/2008The HMGA proteins: a myriad of functions (Review).
1/2008aP2-Cre-mediated expression activation of an oncogenic PLAG1 transgene results in cavernous angiomatosis in mice.
4/2007HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB.
9/2005The tumor suppressor Scrib selectively interacts with specific members of the zyxin family of proteins.
2/2005Transactivation functions of the tumor-specific HMGA2/LPP fusion protein are augmented by wild-type HMGA2.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wim J M Van de Ven Research Topics

Disease

13Neoplasms (Cancer)
06/2016 - 03/2002
5Pleomorphic Adenoma
02/2016 - 03/2002
3Lipoma (Lipomata)
02/2009 - 01/2003
2Carcinogenesis
10/2004 - 07/2004
1Carcinoma (Carcinomatosis)
08/2013
1Colonic Neoplasms (Colon Cancer)
08/2013
1Hepatocellular Carcinoma (Hepatoma)
01/2012
1Hypoglycemia (Reactive Hypoglycemia)
01/2011
1Insulin Resistance
08/2010
1Hyperplasia
08/2010
1Hyperinsulinism (Hyperinsulinemia)
08/2010
1Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome)
12/2008
1Adenomyoepithelioma
10/2008
1Insulinoma
08/2008
1Obesity
11/2007
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2007
1Leukemia
04/2005
1Virus Diseases (Viral Diseases)
12/2004

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
02/2009 - 03/2002
7Transcription Factors (Transcription Factor)IBA
02/2016 - 07/2004
3ZyxinIBA
02/2009 - 01/2005
2CurcuminIBA
06/2016 - 08/2013
2Insulin (Novolin)FDA Link
01/2011 - 08/2010
2FurinIBA
08/2008 - 12/2004
2Insulin-Like Growth Factor II (Somatomedin A)IBA
01/2008 - 04/2007
1PolyphenolsIBA
06/2016
1Insulin-Like PeptidesIBA
02/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2013
1Transforming Growth Factor beta (TGF-beta)IBA
08/2013
1ThapsigarginIBA
08/2013
1Drug CarriersIBA
01/2012
1Glucose (Dextrose)FDA LinkGeneric
01/2011
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2011
1Hormones (Hormone)IBA
01/2011
1Cyclin D1IBA
10/2008
1ProinsulinIBA
08/2008
1HMGA ProteinsIBA
02/2008
1LipidsIBA
11/2007
1Messenger RNA (mRNA)IBA
04/2007
1Carrier Proteins (Binding Protein)IBA
04/2007
1Leucine (L-Leucine)FDA Link
09/2005
1Core Binding Factors (Core-Binding Factor)IBA
04/2005

Therapy/Procedure

2Drug Therapy (Chemotherapy)
06/2016 - 01/2012
1Intravenous Administration
01/2012
1Islets of Langerhans Transplantation
08/2010
1Euthanasia (Mercy Killing)
10/2008
1Therapeutics
12/2004